Approval · Notice of Compliance 8117 · 2006
PMS-RISPERIDONE: Notice of Compliance 8117
Issued July 5, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8117
- Date
- July 5, 2006
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- New dosage form
- Therapeutic class
- Antipsychotic agent
- Canadian reference product
- RISPERDAL (Janssen-Ortho Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-RISPERIDONE | 02279266 | Marketed |
Medicinal ingredients
- RISPERIDONE TARTRATE 1 MG per ML